Bath & Body Works Q3 Results: Adj EPS $0.07-$0.12 vs $0.26 est
- Bath & Body Works projects Q3 adj EPS of $0.07-$0.12
- Analyst estimate for Q3 adj EPS was $0.26
- Q3 sales guidance lowered to $1.514B-$1.554B range
- Previous sales outlook was $1.634B-$1.674B
- Market consensus for sales stood at $1.548B

*this image is generated using AI for illustrative purposes only.
Bath & Body Works (NYSE: BBWI) issued a significant downward revision for its third quarter, projecting adjusted earnings per share (EPS) of $0.07 to $0.12. This range falls sharply below the $0.26 analyst estimate, signaling a substantial miss in profitability expectations for the period.
The retailer also lowered its sales guidance, reducing the top-line outlook from $1.634 billion to $1.674 billion down to $1.514 billion to $1.554 billion. The new midpoint of this revised range sits below the $1.548 billion market consensus, indicating broader pressure on revenue generation.
What the Numbers Show
The divergence between the EPS projection and analyst estimates is stark. The upper bound of the company’s guidance ($0.12) is less than half of the expected $0.26, while the lower bound ($0.07) represents roughly 27% of the estimate. This suggests a material deterioration in either margin performance or volume realization compared to market assumptions.
| Metric | Revised Guidance | Analyst Estimate | Prior Guidance |
|---|---|---|---|
| Adj EPS | $0.07 - $0.12 | $0.26 | N/A |
| Sales | $1.514B - $1.554B | $1.548B | $1.634B - $1.674B |
The simultaneous cut in both top-line and bottom-line metrics points to a comprehensive slowdown. With sales guidance now bracketing the estimate but leaning slightly lower on the midpoint, the primary driver of the EPS miss appears to be margin compression or cost inefficiencies rather than a catastrophic collapse in unit sales alone.
What specific cost drivers or margin pressures are primarily responsible for the disproportionate drop in EPS compared to the moderate decline in sales guidance?
How might Bath & Body Works adjust its inventory management and promotional strategies for the upcoming holiday season to mitigate further revenue erosion?
Will this significant guidance miss trigger a re-evaluation of BBWI's valuation multiples by institutional investors, potentially leading to sustained downward pressure on the stock price?






























